作者
Zhongyu Xie,Di Zhang,Dongjun Chung,Zhanyun Tang,He Huang,Lunzhi Dai,Shankang Qi,Jingya Li,Gozde Colak,Yue Chen,Chunmei Xia,Chao Peng,Hai‐Bin Ruan,Matt Kirkey,Danli Wang,Lindy Jensen,Oh Kwang Kwon,Sangkyu Lee,Scott D. Pletcher,Minjia Tan,David B. Lombard,Kevin P. White,Hongyu Zhao,Jia Li,Robert G. Roeder,Xiaoyong Yang,Yingming Zhao
摘要
Here we report the identification and verification of a β-hydroxybutyrate-derived protein modification, lysine β-hydroxybutyrylation (Kbhb), as a new type of histone mark. Histone Kbhb marks are dramatically induced in response to elevated β-hydroxybutyrate levels in cultured cells and in livers from mice subjected to prolonged fasting or streptozotocin-induced diabetic ketoacidosis. In total, we identified 44 histone Kbhb sites, a figure comparable to the known number of histone acetylation sites. By ChIP-seq and RNA-seq analysis, we demonstrate that histone Kbhb is a mark enriched in active gene promoters and that the increased H3K9bhb levels that occur during starvation are associated with genes upregulated in starvation-responsive metabolic pathways. Histone β-hydroxybutyrylation thus represents a new epigenetic regulatory mark that couples metabolism to gene expression, offering a new avenue to study chromatin regulation and diverse functions of β-hydroxybutyrate in the context of important human pathophysiological states, including diabetes, epilepsy, and neoplasia.